Skip to content
BriaCellBriaCell
  • About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • BriaIMT
    • BriaOTS
    • MOA
    • PKCδ
    • Patents
    • Clinical Trials
    • Scientific Publications
  • Patients
    • What is BriaCell therapy?
    • How can cancer patients get BriaCell therapy?
    • Clinical Trial
    • Expanded Access
  • Recent Media
  • Investor Relations
    • Presentation & Fact Sheet
    • News and Events
    • Filings & Shareholder Info
    • Analyst Coverage
    • Email Alerts
    • Contact Us
Recent Events

Initial Research Report (by RB Milestone Group) – BriaCell Therapeutics Corp. June 21, 2018

Posted on June 21, 2018March 14, 2019 by Chandra Ganegoda

Initial Research Report (by RB Milestone Group) – BriaCell Therapeutics Corp. June 21, 2018arr

This entry was posted in Recent Events. Bookmark the permalink.
ASCO 2018: Interview with Dr. Saveri Bhattacharya on the ongoing Ph I/IIa clinical trial with BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer
BriaCell to Hold Conference Call on Key Clinical Findings; Activities
Recent News
  • BriaCell to Participate at Upcoming Conferences and Appoints Senior R&D Director May 11, 2021
  • BriaCell Announces Investor and Media Outreach Programs April 15, 2021
  • BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million April 12, 2021
  • BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021 April 12, 2021
  • BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021 March 30, 2021
Categories
  • Annual Reports
  • News and Events
    • Recent Events
    • Recent News
Archives
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • June 2015
  • November 2014
  • April 2014

Corporate Office - Canada

Suite 300 - Bellevue Centre, 235 -15th Street,
West Vancouver, BC V7T 2X1

Tel: 604-921-1810
Fax: 604-921-1898

 

Corporate Office - USA

2929 Arch Street, 3rd Floor
Philadelphia, PA 19104

Tel: 1-888-485-6340
Fax: 424-245-3719

  • About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • BriaIMT
    • BriaOTS
    • MOA
    • PKCδ
    • Patents
    • Clinical Trials
    • Scientific Publications
  • Patients
    • What is BriaCell therapy?
    • How can cancer patients get BriaCell therapy?
    • Clinical Trial
    • Expanded Access
  • Recent Media
  • Investor Relations
    • Presentation & Fact Sheet
    • News and Events
    • Filings & Shareholder Info
    • Analyst Coverage
    • Email Alerts
    • Contact Us

Signup for our Email Alert!


    Copyright 2022 © Briacell.| All rights reserved | XML Sitemap | HTML Sitemap
    • About Us
      • About BriaCell
      • Board of Directors
      • Management Team
      • Scientific Advisory Board
      • Corporate Governance
      • Privacy Policy
    • Technology
      • BriaIMT
      • BriaOTS
      • MOA
      • PKCδ
      • Patents
      • Clinical Trials
      • Scientific Publications
    • Patients
      • What is BriaCell therapy?
      • How can cancer patients get BriaCell therapy?
      • Clinical Trial
      • Expanded Access
    • Recent Media
    • Investor Relations
      • Presentation & Fact Sheet
      • News and Events
      • Filings & Shareholder Info
      • Analyst Coverage
      • Email Alerts
      • Contact Us
    • Home
    • Sign Up for Email Alert
    • Careers
    • TSX-V:BCT: (%)
    • NASDAQ:BCTX: (%)